Medtronic Acquires Stimgenics, Pioneer of DTM™, a Novel Spinal Cord Stimulation Therapy
By: Colorado BioScience Association Date: 01/14/2020
Medtronic plc (NYSE:MDT) announced it has acquired Stimgenics, LLC, a privately-held company based in Bloomington, Illinois, that has pioneered a novel spinal cord stimulation (SCS) waveform known as...
Learn MoreCrestone, Inc. (Boulder) Secures CFF Funding for Preclinical Development of Novel Antibiotic to Treat NTM Infections
By: Colorado BioScience Association Date: 01/13/2020
Crestone, Inc. today announced an award from the Cystic Fibrosis Foundation (CFF) for the preclinical development of its antibiotic lead series to treat nontuberculous mycobacteria (NTM) infections, f...
Learn MoreInnosphere Client Company, Vaporox, Raises $1.5M in Seed Funding
By: Colorado BioScience Association Date: 01/13/2020
Vaporox, a Denver-based Innosphere Client Company dedicated to healing diabetic foot ulcers (DFUs), announced this week the closing of its initial round of funding. The $1.5M investment will be used t...
Learn MoreCerebral Therapeutics Completes $35 Million Series B Financing
By: Colorado BioScience Association Date: 01/09/2020
Cerebral Therapeutics, a clinical-stage pharmaceutical company developing innovative treatments for uncontrolled neurological diseases, announced today a $35 million Series B financing led by RA Capit...
Learn MoreMedtronic Expands Surgical Synergy(SM) with FDA Clearance of the Stealth Autoguide™ System for Cranial Procedures
By: Colorado BioScience Association Date: 12/20/2019
Medtronic plc (NYSE:MDT) announced that the U.S. Food and Drug Administration (FDA) recently cleared the Stealth Autoguide™ system, the first cranial robotic platform that integrates with Medtronic’s...
Learn MoreFitzsimons Innovation Community Expands with $55Million Bioscience Facility
By: Colorado BioScience Association Date: 12/13/2019
Fitzsimons Innovation Community, a leading innovation community for visionaries working to transform health and care, announces the expansion of its life sciences campus with the opening of its third...
Learn MoreInscripta Raises $125M in Series D Financing to Accelerate Commercialization of Revolutionary Digital Genome Engineering Platform
By: Colorado BioScience Association Date: 12/10/2019
Inscripta, Inc., today announced the company has raised $125 million in a Series D financing with support from the company’s existing investors and new investors JS Capital Management LLC and Oak HC/F...
Learn MoreAVITA Medical Teams With Gates Center to Advance Therapeutic Skin Restoration
By: Colorado BioScience Association Date: 12/05/2019
AVITA Medical (ASX: AVH, NASDAQ: RCEL), a regenerative medicine company with a technology platform positioned to address unmet medical needs in therapeutic skin restoration, and scientists at the...
Learn MoreBond Pet Foods Completes $1.2 Million Seed Funding Round
By: Colorado BioScience Association Date: 12/05/2019
Bond Pet Foods, Inc., the Boulder-based company working with biotechnology to make nutritious, animal-free and protein-rich pet food, announced today that it has completed its Seed funding, totaling $...
Learn MoreArcherDX Announces Partnership with Illumina to Develop In-Vitro Diagnostic Tests
By: Colorado BioScience Association Date: 12/04/2019
ArcherDX, Inc., a growth-stage molecular diagnostics company dedicated to developing breakthrough solutions that advance personalized genomic medicine, today announced a non-exclusive partnership with...
Learn More